Cargando…
Current Strategies for Modulating Tumor-Associated Macrophages with Biomaterials in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the fourth most common cause of cancer-related deaths in the world. However, there are currently few clinical diagnosis and treatment options available, and there is an urgent need for novel effective approaches. More research is being undertaken on immune-associate...
Autores principales: | Liu, Qiaoyun, Huang, Wei, Liang, Wenjin, Ye, Qifa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004660/ https://www.ncbi.nlm.nih.gov/pubmed/36903458 http://dx.doi.org/10.3390/molecules28052211 |
Ejemplares similares
-
Targeting tumor-associated macrophages in hepatocellular carcinoma: biology, strategy, and immunotherapy
por: Zheng, Hongyu, et al.
Publicado: (2023) -
Circulating tumour cell combined with DNA methylation for early detection of hepatocellular carcinoma
por: Liang, Wenjin, et al.
Publicado: (2022) -
The Role of Tumor Associated Macrophages in Hepatocellular Carcinoma
por: Huang, Yu, et al.
Publicado: (2021) -
Biomaterials delivery strategies to repair spinal cord injury by
modulating macrophage phenotypes
por: Xia, Yuanliang, et al.
Publicado: (2022) -
Current Strategies for the Treatment of Hepatocellular Carcinoma by Modulating the Tumor Microenvironment via Nano-Delivery Systems: A Review
por: Huang, Yongjie, et al.
Publicado: (2022)